Exercises for Your Abs

Companies make the antibodies, but it’s up to you to make sure they work in your experiments.

Written byAmber Dance
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

© ISTOCK.COM/TECHNOTR; BADGE COURTESY OF SCIENCE EXCHANGEStephan Lange had his figures all ready for the manuscript when he decided to double-check his antibody. The University of California, San Diego, cell biologist stained tissue samples from a mouse missing the G-protein–coupled receptor he was interested in, figuring the antibody wouldn’t give him a signal.

But it did. He cut the figure based on that antibody from his manuscript. The rest of the story stood, though it was a bit less interesting for the loss, Lange said.

Lange is far from alone in his disappointment. Antibodies are some of the most commonly used and commonly flawed reagents in biology labs, and pricey, too. Lange points out that the typical commercial antibody—at, say, $200–500 for 100 micrograms, or $2,000–5,000 per gram—costs more than gold ($35.29 per gram as of Jan 12, 2016). But scientists say there’s a lot of fool’s gold in them thar antibody catalogs. In one study of more than 5,000 commercial antibodies, only half worked in both Western blotting and immunohistochemistry (Mol Cell Proteomics, 7:2019-27, 2008). Some researchers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Amber Dance is an award-winning freelance science journalist based in Southern California. After earning a doctorate in biology, she re-trained in journalism as a way to engage her broad interest in science and share her enthusiasm with readers. She mainly writes about life sciences, but enjoys getting out of her comfort zone on occasion.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies